These findings counter clinical trial results published in June which found that Paxlovid was safe to take but did not lessen ...

A detailed examination of how patients respond to the drug at various times and doses provides greater context to a recent ...

A study indicates that longer Paxlovid treatments could improve long COVID symptoms in some patients, highlighting the need ...

The drug, Paxlovid, an oral antiviral treatment made by Pfizer, is lauded by experts as a powerful tool to prevent severe outcomes of COVID-19, like hospitalizations and death. But a recent study ...

An extended course of the antiviral medication Paxlovid may offer relief to individuals suffering from long COVID, suggests a study by UC San Francisco researchers. With around 17.6 million Americans ...

C Midwest Express Clinic. Learn about how COVID-19 has evolved and what you can do to mitigate the spread of the virus.

Range Financial Group LLC purchased a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the fourth quarter, according ...

Shares of the battered biotech Vir Biotechnology were up more than 70% on Wednesday, as the company reported its first ...

Decent snowfall across parts of the lakeshore Wednesday evening. (Jan. 8, 2024) Michigan’s newly elected state representatives took their oaths of office in Lansing Wednesday, marking the beginning of ...

Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, ...

Researchers have found that a combination of dietitian and peer-supported weight management may help improve symptoms in ...

He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...